Skip to main content
Livermore
Livermore
ZHEN

Legend Biotech Corp

LEGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001801198

In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 2 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

Superinvestors holding LEGN, Q2 2026

1 superinvestor reports holding Legend Biotech Corp on Form 13F, worth $172.8M in total. Weight is Legend Biotech Corp's share of each 13F portfolio; actions compare shares with Q1 2026.

See all superinvestors
Superinvestors holding LEGN in Q2 2026
Superinvestor% of portfolioSharesValuevs. previous quarter
HHLR Advisors (Hillhouse)Zhang Lei20.8%5,984,550$172.8MUnchanged

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of LEGN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2025

    1 superinvestor holding at quarter end

    Sold out
    Greenwoods Asset Management

  2. Q1 2025

    2 superinvestors holding at quarter end

    Added
    Greenwoods Asset Management (+36.3%)

  3. Q4 2024

    2 superinvestors holding at quarter end

    Reduced
    HHLR Advisors (Hillhouse) (−9.8%)

  4. Q3 2024

    2 superinvestors holding at quarter end

    New
    Greenwoods Asset Management

  5. Q2 2024

    1 superinvestor holding at quarter end

    Added
    HHLR Advisors (Hillhouse) (+10.9%)
    Sold out
    Duquesne Family Office

  6. Q1 2024

    2 superinvestors holding at quarter end

    New
    Duquesne Family Office

  7. Q4 2023

    1 superinvestor holding at quarter end

    Reduced
    HHLR Advisors (Hillhouse) (−7.0%)
    Sold out
    Soros Fund Management

  8. Q3 2023

    2 superinvestors holding at quarter end

    New
    Soros Fund Management

  9. Q2 2023

    1 superinvestor holding at quarter end

    Added
    HHLR Advisors (Hillhouse) (+25.5%)

  10. Q1 2023

    1 superinvestor holding at quarter end

    Reduced
    HHLR Advisors (Hillhouse) (−0.1%)

  11. Q3 2022

    1 superinvestor holding at quarter end

    Added
    HHLR Advisors (Hillhouse) (+15.8%)

  12. Q2 2022

    1 superinvestor holding at quarter end

    Reduced
    HHLR Advisors (Hillhouse) (−36.0%)

  13. Q1 2022

    1 superinvestor holding at quarter end

    Reduced
    HHLR Advisors (Hillhouse) (−41.2%)

  14. Q4 2021

    1 superinvestor holding at quarter end

    Added
    HHLR Advisors (Hillhouse) (+6.8%)

  15. Q3 2021

    1 superinvestor holding at quarter end

    Added
    HHLR Advisors (Hillhouse) (+1,600.8%)